K Number
K971051
Device Name
IMMULITE THYROID AUTOANTIBODY CONTROL MODULE
Date Cleared
1997-04-10

(17 days)

Product Code
Regulation Number
862.1660
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
Device intended as an aid in monitoring the performance of the IMMULITE® Anti-TPO Ab assay.
Device Description
IMMULITE® Thyroid Autoantibody Control Module is an assayed, bi-level control intended for use with the IMMULITE® Anti-TPO Ab assay. It is intended strictly for in vitro diagnostic use.
More Information

No
The summary describes a control module for an immunoassay, which is a standard laboratory control material. There is no mention of AI, ML, or any computational analysis beyond potentially basic quality control calculations.

No.
The device is described as an "assayed, bi-level control intended for use with the IMMULITE® Anti-TPO Ab assay" and "strictly for in vitro diagnostic use." It is a control module for monitoring the performance of an assay, not for directly treating or diagnosing a medical condition in a patient.

Yes
The "Device Description" explicitly states, "It is intended strictly for in vitro diagnostic use."

No

The device description clearly states it is an "assayed, bi-level control" intended for use with an assay, indicating it is a physical control material, not software.

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

  • Explicit Statement: The "Device Description" section clearly states, "It is intended strictly for in vitro diagnostic use."
  • Intended Use: The "Intended Use / Indications for Use" describes the device as an "aid in monitoring the performance of the IMMULITE® Anti-TPO Ab assay." This indicates it's used to evaluate the performance of another diagnostic test, which is a common function of IVD controls.
  • Device Type: The device is described as a "control module," which is a type of product specifically designed for use in laboratory testing to ensure the accuracy and reliability of diagnostic assays.

Therefore, based on the provided information, this device is an IVD.

N/A

Intended Use / Indications for Use

IMMULITE® Thyroid Autoantibody Control Module is an assayed, bi-level control intended for use with the IMMULITE® Anti-TPO Ab assay. It is intended strictly for in vitro diagnostic use.

Product codes

75-JJX

Device Description

IMMULITE® Thyroid Autoantibody Control Module

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not applicable

Key Metrics

Not Found

Predicate Device(s)

K962975

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 862.1660 Quality control material (assayed and unassayed).

(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

0

K971051

Deagnostic Products Corporation IMMULITE® Thyroid Autoantibody Control Module March 21,1997

510 (k) Summary Safety and Effectiveness

APR 1 0 1997

This summary of safety and effectiveness information has been prepared in accordance with the requirements of SMDA 1990 and 21 CFR Part 807.92.

Name: Address:

Telephone Number: Facsimile Number: Contact Person:

Date of Preparation:

Device Name: Module Trade:

Catalog Number: Classification: Manufacturer:

Sole U.S. Importer:

Establishment Registration #:

Substantially Equivalent Predicate Device:

Description of Device: Intended Use of the Device:

Clinical Studies:

Diagnostic Products Corporation 5700 West 96th Street Los Angeles, California 90045-5597

(213) 776-0180 (213) 776-0204

Edward M. Levine, Ph.D.
Director of Clinical Affairs

March 21, 1997

IMMULITE® Thyroid Autoantibody Control

Device intended as an aid in monitoring the performance of the IMMULITE® Anti-TPO Ab assay.

LAACM

Class I device, 75-JJX (21 CFR 862.1660) EURO/DPC Ltd., a wholly-owned subsidiary of DPC Glyn Rhonwy Llanberis. Gwynedd LL55 4EL United Kingdom (Manufacturing under a Quality System-ISO 9002/EN29002/BS 5750)

Diagnostic Products Corporation (DPC) 5700 West 96th Street Los Angeles, CA 90045-5597

EURO/DPC: Not Applicable DPC: 2017183

DPC's PSA Control Module (K962975)

Quality Control Material

IMMULITE® Thyroid Autoantibody Control Module is an assayed, bi-level control intended for use with the IMMULITE® Anti-TPO Ab assay. It is intended strictly for in vitro diagnostic use.

Not applicable

1

K971051

Diagnostic Products Corporation IMMULITE® Thyroid Autoantibody Control Module March 21, 1997

Conclusion:

ﺳﻴﺪ

The conclusions drawn from the nopclinical tests demonstrate that the device is safe and effective.

Edward Laurie

Edward M. Levine, Ph.D. Director of Clinical Affairs

3/21/97
Date

Date